✦ LIBER ✦

CYP2C19 genotype-based phase I studies of a c-Met inhibitor tivantinib in combination with erlotinib, in advanced/metastatic non-small cell lung cancer

✍ Scribed by Yamamoto, N; Murakami, H; Hayashi, H; Fujisaka, Y; Hirashima, T; Takeda, K; Satouchi, M; Miyoshi, K; Akinaga, S; Takahashi, T; Nakagawa, K

Book ID: 121385542
Publisher: Nature Publishing Group
Year: 2013
Tongue: English
Weight: 212 KB
Volume: 109
Category: Article
ISSN: 0007-0920
DOI: 10.1038/bjc.2013.588

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

303 Combination Effect of Tivantinib wit

303 Combination Effect of Tivantinib with Erlotinib On Cell Proliferation, C-Met Signals and Apoptosis in a Human Non-small Cell Lung Cancer Cell Line

✍ Koizumi, F.; Ishii, K.; Soga, S.; Akinaga, S.; Ishida, H.; Takahashi, T. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Randomized Phase II Trial of Onartuzumab

Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non-Small-Cell Lung Cancer

✍ Spigel, D. R.; Ervin, T. J.; Ramlau, R. A.; Daniel, D. B.; Goldschmidt, J. H.; B 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 266 KB

Rationale and Design of MARQUEE: A Phase

Rationale and Design of MARQUEE: A Phase III, Randomized, Double-Blind Study of Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib in Previously Treated Patients With Locally Advanced or Metastatic, Nonsquamous, Non–Small-Cell Lung Cancer

✍ Giorgio V. Scagliotti; Silvia Novello; Joan H. Schiller; Vera Hirsh; Lecia V. Se 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 332 KB

Phase I dose-escalation study of oral vi

Phase I dose-escalation study of oral vinflunine in combination with erlotinib in pre-treated and unselected EGFR patients with locally advanced or metastatic non-small-cell lung cancer

✍ Krzakowski, M.; Bennouna, J.; Dansin, E.; Kowalski, D.; Hiret, S.; Penel, N.; Fa 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 316 KB

A phase II study of enzastaurin in combi

A phase II study of enzastaurin in combination with erlotinib in patients with previously treated advanced non-small cell lung cancer

✍ Clément-Duchêne, Christelle; Natale, Ronald B.; Jahan, Thierry; Krupitskaya, Yel 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 300 KB

A phase II study of mitomycin C, vindesi

A phase II study of mitomycin C, vindesine and cisplatin combined with alpha interferon in advanced non-small cell lung cancer

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 143 KB